Specialty
Eye care news should explain what changed, who was studied, which endpoint moved, how large and durable the effect was, what harms occurred, who funded.
Articles
Eye Care News
A circulating tumor DNA test for uveal melanoma monitoring is available in the United States as a laboratory-developed test from a CLIA-certified, CAP-accredited laboratory.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
A useful family guide should compare myopia-control options by evidence, regulatory status, age and prescription limits, daily burden, safety, cost, and follow-up instead of declaring one universal winner.
7 min read · Updated Aug 1, 2026
Read article
Eye Care News
The Bi-Blade dual-port vitrectomy cutter launched in Europe as a surgical instrument for vitreoretinal procedures.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
A wireless intracortical visual prosthesis is in a small phase 1 feasibility study, not routine care.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
FDA-authorized autonomous AI systems can analyze retinal photographs for diabetic retinopathy in eligible patients at primary-care or diabetes visits.
7 min read · Updated Aug 1, 2026
Read article
Eye Care News
Ask Kate is a Myopia Profile educational assistant available to families through MyKidsVision. It can organize questions but cannot examine a child or choose treatment.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
BrightMEM is a donor-derived Descemet membrane allograft for selected corneal procedures. Its product insert defines the tissue and its handling, not comparative outcomes.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
Diet research may identify patterns associated with age-related macular degeneration, but association does not prove that one food prevents or reverses disease.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
Randomized trials suggest DOT spectacle lenses can slow myopia progression in studied children, but FDA Breakthrough Device designation is not marketing authorization or approval.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
Elegrobart remains an investigational subcutaneous therapy, and positive company-reported phase 3 results do not make it FDA-approved or routinely available.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
MCO-010 is an investigational optogenetic therapy studied in adults with severe vision loss from retinitis pigmentosa. Trial reports do not make it routine care.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
The MiSight Switch Program is a commercial program, not a new clinical endpoint or proof that one child will respond better.
7 min read · Updated Aug 1, 2026
Read article
Eye Care News
Early MiYOSMART iQ reports add to research on spectacle-based myopia control, but the findings came from non-U.S.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
A company-commissioned prospective study followed 30 established progressive-lens wearers aged 40 or older at six U.S.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
FDA-approved WaveLight Plus uses patient-specific ray-tracing measurements to plan LASIK, but it does not make every eye a candidate or remove surgical risk.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
A 2026 pooled analysis found no short-term pressure rise with the specific skin or oral steroid regimens studied. The result does not establish safety for steroid eye drops.
6 min read · Updated Aug 1, 2026
Read article
Eye Care News
Vamikibart remains investigational. In phase 3 uveitic macular edema research, MEERKAT met its primary endpoint while SANDCAT did not, so the program cannot be summarized as two uniformly positive trials. The findings support.
7 min read · Updated Aug 1, 2026
Read article
Eye Care News
Vision-training software is not one treatment category. A prescription digital therapy may have a specific FDA-cleared indication and age range, while another program may be investigational or a general wellness product. Patients.
7 min read · Updated Aug 1, 2026
Read article
Eye Care News
Eye-drop recall status can change, so patients should check the exact product, manufacturer, lot, and current FDA recall notice rather than rely on an old list.
7 min read · Updated Aug 1, 2026
Read article
Eye Care News
FDA-cleared FSYX Ocular Pressure Adjusting Pump goggles are a prescription system that temporarily lowers intraocular pressure during wear in adults with open-angle glaucoma.
6 min read · Updated Aug 1, 2026
Read article